Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1178879.
Total stock buying since 2007: $164,927,777.
Total stock sales since 2007: $289,464,081.
Total stock option exercises since 2007: $43,076,426.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 400 | $4,000 | 400 | $3,611 |
| 2024 | 0 | $0 | 399,658 | $5,124,634 | 182,067 | $1,360,541 |
| 2023 | 0 | $0 | 813,767 | $10,307,679 | 457,240 | $2,081,221 |
| 2022 | 0 | $0 | 424,370 | $4,449,738 | 116,155 | $466,726 |
| 2021 | 45,105 | $451,689 | 557,791 | $7,173,882 | 411,757 | $2,127,182 |
| 2020 | 11,000 | $175,512 | 1,681,390 | $24,511,559 | 1,284,060 | $8,873,723 |
| 2019 | 4,945 | $49,796 | 572,269 | $6,783,107 | 547,724 | $2,955,368 |
| 2018 | 1,235,827 | $15,744,014 | 301,765 | $4,590,161 | 201,765 | $1,644,814 |
| 2017 | 1,501,395 | $18,395,032 | 971,072 | $12,606,562 | 913,823 | $11,449,856 |
| 2016 | 592,950 | $3,020,945 | 1,260,420 | $8,649,277 | 156,358 | $50,864 |
| 2015 | 810,000 | $5,440,410 | 1,080,786 | $13,931,432 | 1,273,641 | $11,766,749 |
| 2014 | 6,467,084 | $30,224,665 | 11,682,909 | $62,446,695 | 16,491 | $10,521 |
| 2013 | 1,525,000 | $3,085,000 | 0 | $0 | 0 | $0 |
| 2012 | 9,361,554 | $55,128,673 | 0 | $0 | 49,931 | $31,955 |
| 2011 | 30,000 | $162,800 | 2,250 | $16,875 | 2,250 | $1,435 |
| 2010 | 11,898 | $43,903 | 0 | $0 | 0 | $0 |
| 2009 | 20,000 | $82,600 | 71,908 | $765,927 | 5,924 | $8,466 |
| 2008 | 1,834,162 | $27,685,294 | 677,689 | $127,429,143 | 153,582 | $191,652 |
| 2007 | 461,042 | $5,237,444 | 44,894 | $673,410 | 81,102 | $51,742 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-10-31 | Palling David (Senior VP, Drug Development) | Sale | 2,200 | 10.00 | 22,000 |
| 2008-10-31 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,939 | 10.00 | 19,390 |
| 2008-10-31 | Bloch Stephen M (Director) | Sale | 3,000 | 9.85 | 29,550 |
| 2008-10-30 | Palling David (Senior VP, Drug Development) | Sale | 300 | 10.00 | 3,000 |
| 2008-10-30 | Patterson Matthew R (Chief Operating Officer) | Sale | 361 | 10.00 | 3,610 |
| 2008-10-30 | Bloch Stephen M (Director) | Sale | 3,000 | 9.54 | 28,626 |
| 2008-10-29 | Bloch Stephen M (Director) | Sale | 3,000 | 8.51 | 25,539 |
| 2008-10-28 | Crowley John F (President & CEO) | Option Ex | 40,000 | 2.98 | 119,240 |
| 2008-10-28 | Bloch Stephen M (Director) | Sale | 2,601 | 8.50 | 22,108 |
| 2008-10-27 | Bloch Stephen M (Director) | Sale | 2,942 | 8.88 | 26,139 |
| 2008-10-24 | Bloch Stephen M (Director) | Sale | 3,000 | 9.70 | 29,097 |
| 2008-10-23 | Patterson Matthew R (Chief Operating Officer) | Sale | 100 | 10.10 | 1,010 |
| 2008-10-23 | Bloch Stephen M (Director) | Sale | 3,000 | 9.76 | 29,265 |
| 2008-10-22 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,100 | 10.40 | 32,246 |
| 2008-10-22 | Bloch Stephen M (Director) | Sale | 3,000 | 10.47 | 31,425 |
| 2008-10-21 | Patterson Matthew R (Chief Operating Officer) | Sale | 5,000 | 10.51 | 52,524 |
| 2008-10-21 | Bloch Stephen M (Director) | Sale | 3,000 | 10.51 | 31,539 |
| 2008-10-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,000 | 11.12 | 44,484 |
| 2008-10-20 | Bloch Stephen M (Director) | Sale | 6,000 | 10.59 | 63,522 |
| 2008-10-17 | Bloch Stephen M (Director) | Sale | 6,000 | 10.75 | 64,494 |
| 2008-10-16 | Bloch Stephen M (Director) | Sale | 3,000 | 10.51 | 31,536 |
| 2008-10-15 | Bloch Stephen M (Director) | Sale | 3,000 | 11.02 | 33,066 |
| 2008-10-14 | Bloch Stephen M (Director) | Sale | 3,000 | 12.41 | 37,218 |
| 2008-10-13 | Bloch Stephen M (Director) | Sale | 3,000 | 13.17 | 39,501 |
| 2008-10-06 | Crowley John F (President & CEO) | Sale | 2,300 | 14.76 | 33,936 |
| 2008-10-03 | Crowley John F (President & CEO) | Sale | 3,700 | 14.97 | 55,377 |
| 2008-10-02 | Crowley John F (President & CEO) | Sale | 5,200 | 15.10 | 78,498 |
| 2008-10-01 | Crowley John F (President & CEO) | Sale | 2,800 | 15.08 | 42,226 |
| 2008-09-29 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 15.62 | 39,062 |
| 2008-09-22 | Bloch Stephen M (Director) | Sale | 2,829 | 16.02 | 45,312 |
| 2008-09-19 | Bloch Stephen M (Director) | Sale | 11,129 | 16.42 | 182,727 |
| 2008-09-18 | Bloch Stephen M (Director) | Sale | 3,300 | 15.02 | 49,556 |
| 2008-09-17 | Bloch Stephen M (Director) | Sale | 3,000 | 14.13 | 42,387 |
| 2008-09-16 | Bloch Stephen M (Director) | Sale | 3,000 | 14.13 | 42,378 |
| 2008-09-15 | Bloch Stephen M (Director) | Sale | 4,400 | 14.07 | 61,912 |
| 2008-09-12 | Bloch Stephen M (Director) | Sale | 3,000 | 14.09 | 42,279 |
| 2008-09-11 | Bloch Stephen M (Director) | Sale | 3,000 | 14.71 | 44,133 |
| 2008-09-10 | Bloch Stephen M (Director) | Sale | 3,000 | 13.78 | 41,325 |
| 2008-09-09 | Bloch Stephen M (Director) | Sale | 5,700 | 13.79 | 78,597 |
| 2008-09-08 | Palling David (Senior VP, Drug Development) | Sale | 3,000 | 14.83 | 44,496 |
| 2008-09-08 | Bloch Stephen M (Director) | Sale | 3,000 | 14.91 | 44,733 |
| 2008-09-05 | Crowley John F (President and CEO) | Sale | 2,500 | 13.74 | 34,355 |
| 2008-09-05 | Bloch Stephen M (Director) | Sale | 3,000 | 13.75 | 41,250 |
| 2008-09-04 | Crowley John F (President and CEO) | Sale | 2,500 | 13.84 | 34,597 |
| 2008-09-04 | Bloch Stephen M (Director) | Sale | 3,000 | 13.76 | 41,271 |
| 2008-09-03 | Crowley John F (President & CEO) | Sale | 2,500 | 13.77 | 34,412 |
| 2008-09-03 | Bloch Stephen M (Director) | Sale | 3,000 | 13.72 | 41,172 |
| 2008-09-02 | Crowley John F (President & CEO) | Sale | 2,600 | 13.78 | 35,838 |
| 2008-09-02 | Bloch Stephen M (Director) | Sale | 6,000 | 3,463.36 | 20,780,154 |
| 2008-08-29 | Bloch Stephen M (Director) | Sale | 6,000 | 13.79 | 82,758 |
| 2008-08-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 13.77 | 34,425 |
| 2008-08-28 | Bloch Stephen M (Director) | Sale | 3,000 | 13.81 | 41,427 |
| 2008-08-27 | Bloch Stephen M (Director) | Sale | 3,000 | 13.89 | 41,685 |
| 2008-08-26 | Crowley John F (President and CEO) | Sale | 13,333 | 13.61 | 181,475 |
| 2008-08-26 | Bloch Stephen M (Director) | Sale | 4,200 | 13.64 | 57,283 |
| 2008-08-25 | Bloch Stephen M (Director) | Sale | 3,000 | 13.67 | 41,004 |
| 2008-08-22 | Bloch Stephen M (Director) | Sale | 3,000 | 13.52 | 40,569 |
| 2008-08-21 | Bloch Stephen M (Director) | Sale | 3,000 | 13.57 | 40,719 |
| 2008-08-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 2,000 | 13.54 | 27,070 |
| 2008-08-20 | Bloch Stephen M (Director) | Sale | 3,000 | 13.72 | 41,160 |
| 2008-08-19 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,500 | 14.10 | 63,468 |
| 2008-08-19 | Bloch Stephen M (Director) | Sale | 3,000 | 13.56 | 40,671 |
| 2008-08-18 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,500 | 15.53 | 54,358 |
| 2008-08-18 | Licholai Gregory P (VP, Medical Affairs) | Sale | 1,401 | 15.11 | 21,163 |
| 2008-08-18 | Licholai Gregory P (VP, Medical Affairs) | Option Ex | 1,401 | .64 | 892 |
| 2008-08-18 | Bloch Stephen M (Director) | Sale | 3,000 | 15.14 | 45,420 |
| 2008-08-15 | Bloch Stephen M (Director) | Sale | 3,000 | 16.46 | 49,382 |
| 2008-08-15 | Sblendorio Glenn (Director) | Sale | 1,400 | 16.74 | 23,438 |
| 2008-08-14 | Weinhoff Gregory M (Director) | Sale | 50,000 | 17.00 | 850,000 |
| 2008-08-14 | Bloch Stephen M (Director) | Sale | 10,066 | 17.03 | 171,444 |
| 2008-08-13 | Schaeffer Orlov S Nicole (Sr. VP, HR & Lead.Devlop.) | Sale | 5 | 18.00 | 90 |
| 2008-08-13 | Bloch Stephen M (Director) | Sale | 5,700 | 17.57 | 100,154 |
| 2008-08-12 | Schaeffer Orlov S Nicole (Sr. VP, HR & Lead.Devlop.) | Sale | 208 | 18.00 | 3,744 |
| 2008-08-12 | Bloch Stephen M (Director) | Sale | 7,620 | 16.97 | 129,288 |
| 2008-08-11 | Bloch Stephen M (Director) | Sale | 3,500 | 16.82 | 58,859 |
| 2008-08-08 | Bloch Stephen M (Director) | Sale | 3,000 | 16.70 | 50,091 |
| 2008-08-07 | Bloch Stephen M (Director) | Sale | 4,200 | 16.58 | 69,636 |
| 2008-08-06 | Bloch Stephen M (Director) | Sale | 4,879 | 16.18 | 78,942 |
| 2008-08-05 | Bloch Stephen M (Director) | Sale | 3,000 | 15.55 | 46,662 |
| 2008-08-04 | Crowley John F (President & CEO) | Sale | 6,200 | 15.24 | 94,500 |
| 2008-08-04 | Bloch Stephen M (Director) | Sale | 4,500 | 15.23 | 68,553 |
| 2008-08-01 | Crowley John F (President & CEO) | Sale | 3,800 | 15.42 | 58,603 |
| 2008-08-01 | Bloch Stephen M (Director) | Sale | 3,700 | 15.45 | 57,168 |
| 2008-07-31 | Bloch Stephen M (Director) | Sale | 10,000 | 7,740.23 | 77,402,320 |
| 2008-07-30 | Bloch Stephen M (Director) | Sale | 4,700 | 15.19 | 71,369 |
| 2008-07-29 | Bloch Stephen M (Director) | Sale | 3,600 | 15.30 | 55,087 |
| 2008-07-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 15.08 | 37,692 |
| 2008-07-28 | Bloch Stephen M (Director) | Sale | 9,000 | 15.22 | 137,025 |
| 2008-07-25 | Bloch Stephen M (Director) | Sale | 2,300 | 15.43 | 35,493 |
| 2008-07-24 | Bloch Stephen M (Director) | Sale | 5,661 | 15.23 | 86,245 |
| 2008-07-23 | Bloch Stephen M (Director) | Sale | 1,834 | 15.00 | 27,506 |
| 2008-07-22 | Licholai Gregory P (VP, Medical Affairs) | Sale | 15,000 | 15.00 | 225,000 |
| 2008-07-22 | Licholai Gregory P (VP, Medical Affairs) | Option Ex | 15,000 | .64 | 9,555 |
| 2008-07-22 | Bloch Stephen M (Director) | Sale | 8,589 | 15.01 | 128,877 |
| 2008-07-21 | Bloch Stephen M (Director) | Sale | 7,600 | 14.47 | 109,972 |
| 2008-07-18 | Bloch Stephen M (Director) | Sale | 10,400 | 13.86 | 144,123 |
| 2008-07-17 | Bloch Stephen M (Director) | Sale | 1,600 | 13.38 | 21,401 |
| 2008-07-16 | Bloch Stephen M (Director) | Sale | 1,900 | 13.16 | 25,007 |
| 2008-07-15 | Licholai Gregory P (VP, Medical Affairs) | Sale | 15,000 | 13.00 | 195,000 |
| 2008-07-15 | Licholai Gregory P (VP, Medical Affairs) | Option Ex | 15,000 | .64 | 9,555 |
| 2008-07-15 | Bloch Stephen M (Director) | Sale | 5,600 | 12.89 | 72,212 |
| 2008-07-14 | Bloch Stephen M (Director) | Sale | 1,600 | 12.61 | 20,171 |
| 2008-07-11 | Bloch Stephen M (Director) | Sale | 8,893 | 12.55 | 111,607 |
| 2008-07-07 | Crowley John F (President and CEO) | Sale | 2,200 | 11.09 | 24,391 |
| 2008-07-03 | Crowley John F (President and CEO) | Sale | 1,500 | 10.84 | 16,266 |
| 2008-07-02 | Crowley John F (President and CEO) | Sale | 3,000 | 11.05 | 33,150 |
| 2008-07-01 | Crowley John F (President and CEO) | Sale | 3,300 | 10.72 | 35,385 |
| 2008-06-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,400 | 11.38 | 15,932 |
| 2008-06-19 | Patterson Matthew R (Chief Operating Officer) | Sale | 400 | 11.05 | 4,421 |
| 2008-06-18 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,500 | 11.01 | 16,512 |
| 2008-06-17 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,800 | 11.08 | 19,945 |
| 2008-06-16 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,900 | 11.18 | 54,801 |
| 2008-06-04 | Crowley John F (President and CEO) | Sale | 5,000 | 10.43 | 52,130 |
| 2008-05-02 | Crowley John F (President and CEO) | Sale | 4,795 | 10.45 | 50,088 |
| 2008-05-01 | Crowley John F (President and CEO) | Sale | 5,205 | 10.59 | 55,141 |
| 2008-04-24 | Palling David (Senior VP, Drug Development) | Option Ex | 20,000 | .64 | 12,740 |
| 2008-04-16 | Patterson Matthew R (Chief Operating Officer) | Sale | 578 | 10.00 | 5,780 |
| 2008-04-15 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,422 | 10.17 | 34,808 |
| 2008-04-14 | Patterson Matthew R (Chief Operating Officer) | Sale | 6,000 | 10.61 | 62,987 |
| 2008-04-03 | Crowley John F (President and CEO) | Sale | 3,600 | 11.03 | 39,690 |
| 2008-04-02 | Crowley John F (President and CEO) | Sale | 11,600 | 11.04 | 128,028 |
| 2008-04-01 | Palling David (Senior VP, Drug Development) | Sale | 1,250 | 11.14 | 13,931 |
| 2008-04-01 | Crowley John F (President and CEO) | Sale | 2,400 | 11.10 | 26,632 |
| 2008-03-10 | Topper James N (Director) | Buy | 5,500 | 10.21 | 56,668 |
| 2008-03-10 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 5,500 | 10.21 | 56,668 |
| 2008-03-06 | Topper James N (Director) | Buy | 22,146 | 9.99 | 221,349 |
| 2008-03-06 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 22,146 | 9.99 | 221,349 |
| 2008-03-05 | Topper James N (Director) | Buy | 50,000 | 9.77 | 490,574 |
| 2008-03-05 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 50,000 | 9.77 | 490,574 |
| 2008-03-04 | Crowley John F (President and CEO) | Sale | 5,503 | 10.00 | 55,030 |
| 2008-03-04 | Topper James N (Director) | Buy | 13,500 | 9.83 | 133,343 |
| 2008-03-04 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 13,500 | 9.83 | 133,343 |
| 2008-03-03 | Crowley John F (President and CEO) | Sale | 4,497 | 10.00 | 44,970 |
| 2008-03-03 | Topper James N (Director) | Buy | 62,100 | 268.09 | 10,124,103 |
| 2008-03-03 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 62,100 | 9.80 | 605,452 |
| 2008-02-29 | Crowley John F (President and CEO) | Option Ex | 10,000 | .64 | 6,380 |
| 2008-02-29 | Topper James N (Director) | Buy | 8,637 | 9.88 | 85,333 |
| 2008-02-29 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 8,637 | 9.88 | 85,333 |
| 2008-02-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 10.51 | 26,262 |
| 2008-02-28 | Licholai Gregory P (VP, Medical Affairs) | Sale | 10,000 | 10.04 | 100,440 |
| 2008-02-28 | Topper James N (Director) | Buy | 7,800 | 9.99 | 78,278 |
| 2008-02-28 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 7,800 | 9.99 | 78,278 |
| 2008-02-27 | Topper James N (Director) | Buy | 23,300 | 9.92 | 230,285 |
| 2008-02-27 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 23,300 | 9.92 | 230,285 |
| 2008-02-26 | Topper James N (Director) | Buy | 8,000 | 9.90 | 78,384 |
| 2008-02-26 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 8,000 | 9.90 | 78,384 |
| 2008-02-25 | Topper James N (Director) | Buy | 9,700 | 9.66 | 93,731 |
| 2008-02-25 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 9,700 | 9.66 | 93,731 |
| 2008-02-22 | Topper James N (Director) | Buy | 8,814 | 9.79 | 86,405 |
| 2008-02-22 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 8,814 | 9.79 | 86,405 |
| 2008-02-21 | Patterson Matthew R (Chief Operating Officer) | Option Ex | 12,083 | .64 | 7,708 |
| 2008-02-21 | Topper James N (Director) | Buy | 5,500 | 10.23 | 56,275 |
| 2008-02-21 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 5,500 | 10.23 | 56,275 |
| 2008-02-20 | Topper James N (Director) | Buy | 49,500 | 9.61 | 475,447 |
| 2008-02-20 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 49,500 | 9.61 | 475,447 |
| 2008-02-19 | Topper James N (Director) | Buy | 9,600 | 9.90 | 95,059 |
| 2008-02-19 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 9,600 | 9.90 | 95,059 |
| 2008-02-15 | Topper James N (Director) | Buy | 6,900 | 10.48 | 72,346 |
| 2008-02-15 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 6,900 | 10.48 | 72,346 |
| 2008-02-13 | Topper James N (Director) | Buy | 12,000 | 10.39 | 124,598 |
| 2008-02-13 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 12,000 | 10.39 | 124,598 |
| 2008-02-12 | Topper James N (Director) | Buy | 9,400 | 10.04 | 94,394 |
| 2008-02-12 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 9,400 | 10.04 | 94,394 |
| 2008-02-11 | Topper James N (Director) | Buy | 5,700 | 10.05 | 57,267 |
| 2008-02-11 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 5,700 | 10.05 | 57,267 |
| 2008-02-08 | Topper James N (Director) | Buy | 33,800 | 10.12 | 342,123 |
| 2008-02-08 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 33,800 | 10.12 | 342,123 |
| 2008-02-07 | Topper James N (Director) | Buy | 25,400 | 10.09 | 256,209 |
| 2008-02-07 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 25,400 | 10.09 | 256,209 |
| 2008-02-06 | Topper James N (Director) | Buy | 45,477 | 10.12 | 460,454 |
| 2008-02-06 | Frazier Affiliates Iv Lp (10% Owner) | Buy | 45,477 | 10.12 | 460,454 |
| 2008-02-05 | Fhm V, Llc (10% Owner) | Buy | 68,400 | 10.33 | 706,054 |
| 2008-02-05 | Topper James N (Director) | Buy | 68,400 | 10.33 | 706,054 |
| 2008-02-04 | Fhm V, Llc (10% Owner) | Buy | 59,175 | 10.28 | 609,546 |
| 2008-02-04 | Topper James N (Director) | Buy | 59,175 | 10.28 | 609,546 |
| 2008-02-01 | Palling David (Senior VP, Drug Development) | Sale | 3,000 | 10.00 | 30,000 |
| 2008-02-01 | Crowley John F (President and CEO) | Sale | 10,000 | 10.00 | 100,000 |
| 2008-02-01 | Licholai Gregory P (VP, Medical Affairs) | Sale | 10,000 | 9.90 | 99,000 |
| 2008-02-01 | Fhm V, Llc (10% Owner) | Buy | 80,000 | 9.39 | 756,701 |
| 2008-02-01 | Topper James N (Director) | Buy | 80,000 | 9.26 | 756,701 |
| 2008-01-31 | Fhm V, Lp (10% Owner) | Buy | 22,885 | 10.00 | 228,850 |
| 2008-01-31 | Fhm V, Llc (10% Owner) | Buy | 15,015 | 9.97 | 150,697 |
| 2008-01-31 | Topper James N (Director) | Buy | 37,900 | 9.99 | 379,547 |
| 2008-01-02 | Crowley John F (President and CEO) | Sale | 10,000 | 10.30 | 103,050 |
| 2008-01-02 | Crowley John F (President and CEO) | Option Ex | 20,000 | .64 | 12,760 |
| 2007-12-14 | Crowley John F (President & CEO) | Option Ex | 5,000 | .64 | 3,190 |
| 2007-12-13 | Crowley John F (President & CEO) | Option Ex | 10,000 | .64 | 6,380 |
| 2007-08-24 | Sblendorio Glenn (Director) | Buy | 1,000 | 11.42 | 11,420 |
| 2007-08-15 | Patterson Matthew R (Chief Operating Officer) | Option Ex | 32,366 | .64 | 20,649 |
| 2007-08-08 | Fhm V, Llc (10% Owner) | Buy | 29,600 | 11.50 | 340,400 |
| 2007-08-08 | Topper James N (Director) | Buy | 29,600 | 11.50 | 340,400 |
| 2007-07-27 | Fhm V, Llc (10% Owner) | Buy | 17,800 | 11.37 | 202,332 |
| 2007-07-27 | Topper James N (Director) | Buy | 17,800 | 11.37 | 202,332 |
| 2007-07-26 | Fhm V, Llc (10% Owner) | Buy | 8,000 | 11.39 | 91,113 |
| 2007-07-26 | Topper James N (Director) | Buy | 8,000 | 11.39 | 91,113 |
| 2007-07-25 | Fhm V, Llc (10% Owner) | Buy | 29,700 | 11.42 | 339,174 |
| 2007-07-25 | Topper James N (Director) | Buy | 29,700 | 11.42 | 339,174 |
| 2007-06-29 | Topper James N (Director) | Buy | 13,900 | 11.46 | 159,224 |
| 2007-06-29 | Frazier Healthcare Iv Lp (10% Owner) | Buy | 13,900 | 11.46 | 159,224 |
| 2007-06-28 | Topper James N (Director) | Buy | 9,015 | 11.44 | 103,127 |
| 2007-06-28 | Frazier Healthcare Iv Lp (10% Owner) | Buy | 4,281 | 11.49 | 49,188 |
| 2007-06-27 | Topper James N (Director) | Buy | 144,400 | 11.22 | 1,624,742 |
| 2007-06-21 | Crowley John F (President & CEO) | Option Ex | 33,736 | .64 | 21,523 |
| 2007-06-05 | Trainor Iii Eugene A (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Hirsch Russell C (10% Owner) | Sale | 6,427 | 15.00 | 96,405 |
| 2007-06-05 | Barkas Alexander E (Director) | Sale | 6,427 | 15.00 | 96,405 |
| 2007-06-05 | Perry Mark W (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Barris Peter J (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Kramlich C Richard (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Newhall Charles W Iii (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.